These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32544501)

  • 1. Subanesthetic ketamine exerts antidepressant-like effects in adult rats exposed to juvenile stress.
    Aikawa K; Yoshida T; Ohmura Y; Lyttle K; Yoshioka M; Morimoto Y
    Brain Res; 2020 Nov; 1746():146980. PubMed ID: 32544501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway.
    Jett JD; Boley AM; Girotti M; Shah A; Lodge DJ; Morilak DA
    Psychopharmacology (Berl); 2015 Sep; 232(17):3123-33. PubMed ID: 25986748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
    Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
    Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine Strengthens CRF-Activated Amygdala Inputs to Basal Dendrites in mPFC Layer V Pyramidal Cells in the Prelimbic but not Infralimbic Subregion, A Key Suppressor of Stress Responses.
    Liu RJ; Ota KT; Dutheil S; Duman RS; Aghajanian GK
    Neuropsychopharmacology; 2015 Aug; 40(9):2066-75. PubMed ID: 25759300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.
    Liu RJ; Fuchikami M; Dwyer JM; Lepack AE; Duman RS; Aghajanian GK
    Neuropsychopharmacology; 2013 Oct; 38(11):2268-77. PubMed ID: 23680942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats.
    Parise EM; Alcantara LF; Warren BL; Wright KN; Hadad R; Sial OK; Kroeck KG; Iñiguez SD; Bolaños-Guzmán CA
    Biol Psychiatry; 2013 Nov; 74(10):750-9. PubMed ID: 23790225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine.
    Dong C; Zhang JC; Yao W; Ren Q; Ma M; Yang C; Chaki S; Hashimoto K
    Int J Neuropsychopharmacol; 2017 Mar; 20(3):228-236. PubMed ID: 27765808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray.
    Chou D; Peng HY; Lin TB; Lai CY; Hsieh MC; Wen YC; Lee AS; Wang HH; Yang PS; Chen GD; Ho YC
    Neuropharmacology; 2018 Sep; 139():1-12. PubMed ID: 29953886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated fluvoxamine treatment recovers juvenile stress-induced morphological changes and depressive-like behavior in rats.
    Lyttle K; Ohmura Y; Konno K; Yoshida T; Izumi T; Watanabe M; Yoshioka M
    Brain Res; 2015 Aug; 1616():88-100. PubMed ID: 25960352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-methyl-D-aspartate receptor antagonist d-methadone acutely improves depressive-like behavior in the forced swim test performance of rats.
    Hanania T; Manfredi P; Inturrisi C; Vitolo OV
    Exp Clin Psychopharmacol; 2020 Apr; 28(2):196-201. PubMed ID: 31368772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
    Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats.
    Wan YQ; Feng JG; Li M; Wang MZ; Liu L; Liu X; Duan XX; Zhang CX; Wang XB
    Exp Mol Med; 2018 Oct; 50(10):1-14. PubMed ID: 30369596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.
    Brand SJ; Harvey BH
    Acta Neuropsychiatr; 2017 Aug; 29(4):207-221. PubMed ID: 27692010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant actions of ketamine engage cell-specific translation via eIF4E.
    Aguilar-Valles A; De Gregorio D; Matta-Camacho E; Eslamizade MJ; Khlaifia A; Skaleka A; Lopez-Canul M; Torres-Berrio A; Bermudez S; Rurak GM; Simard S; Salmaso N; Gobbi G; Lacaille JC; Sonenberg N
    Nature; 2021 Feb; 590(7845):315-319. PubMed ID: 33328636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of Egr-1 Expression Level via GluN2B Underlies the Antidepressant Effects of Ketamine in a Chronic Unpredictable Stress Animal Model of Depression.
    Zhang WJ; Wang HH; Lv YD; Liu CC; Sun WY; Tian LJ
    Neuroscience; 2018 Feb; 372():38-45. PubMed ID: 29294341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine.
    Carreno FR; Donegan JJ; Boley AM; Shah A; DeGuzman M; Frazer A; Lodge DJ
    Mol Psychiatry; 2016 Sep; 21(9):1298-308. PubMed ID: 26619811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant effects of ketamine on depression-related phenotypes and dopamine dysfunction in rodent models of stress.
    Rincón-Cortés M; Grace AA
    Behav Brain Res; 2020 Feb; 379():112367. PubMed ID: 31739001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
    Koike H; Chaki S
    Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine.
    Shaffer CL; Dutra JK; Tseng WC; Weber ML; Bogart LJ; Hales K; Pang J; Volfson D; Am Ende CW; Green ME; Buhl DL
    Neuropharmacology; 2019 Jul; 153():73-81. PubMed ID: 31015046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between ketamine's short-term and long-term effects on brain circuitry in depression.
    Gass N; Becker R; Reinwald J; Cosa-Linan A; Sack M; Weber-Fahr W; Vollmayr B; Sartorius A
    Transl Psychiatry; 2019 Jun; 9(1):172. PubMed ID: 31253763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.